Patents by Inventor Christine Watson

Christine Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076284
    Abstract: The present invention relates to compounds of Formula (I) that are inhibitors of c-ABL. The invention also relates to pharmaceutical compositions comprising those compounds, and to their use in the treatment or prevention of medical conditions in which inhibition of c-ABL is beneficial. Such medical conditions include neurodegenerative diseases and cancer.
    Type: Application
    Filed: December 16, 2021
    Publication date: March 7, 2024
    Applicant: BENEVOLENTAI BIO LIMITED
    Inventors: Rebecca PAUL, Michael John RAWLING, Christine WATSON
  • Patent number: 11766483
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: September 26, 2023
    Assignee: CENTAURI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Michael Westby, Melanie Glossop, Christine Watson, Christopher Pickford
  • Publication number: 20220313776
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: June 13, 2022
    Publication date: October 6, 2022
    Inventors: Michael Westby, Melanie GLOSSOP, Christine WATSON
  • Patent number: 11406683
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: August 9, 2022
    Assignee: CENTAURI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Michael Westby, Melanie Glossop, Christine Watson
  • Publication number: 20220162262
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: April 1, 2020
    Publication date: May 26, 2022
    Inventors: Melanie GLOSSOP, Christine WATSON
  • Publication number: 20210369850
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: March 1, 2021
    Publication date: December 2, 2021
    Inventors: Christopher Pickford, Christine WATSON, Melanie GLOSSOP
  • Publication number: 20210353765
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: October 10, 2019
    Publication date: November 18, 2021
    Inventors: Michael WESTBY, Melanie GLOSSOP, Christopher PICKFORD, Christine WATSON
  • Patent number: 11130730
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: September 28, 2021
    Assignee: CENTAURI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Melanie Glossop, Christine Watson
  • Patent number: 11014966
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: May 25, 2021
    Assignee: CENTUARI THERAPEUTICS LIMITED
    Inventors: Melanie Glossop, Christine Watson, Michael Westby
  • Publication number: 20210085798
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: March 14, 2019
    Publication date: March 25, 2021
    Applicant: Centauri Therapeutics Limited
    Inventors: Melanie GLOSSOP, Christine WATSON
  • Patent number: 10953100
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: March 23, 2021
    Assignee: CENTUARI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Christopher Pickford, Christine Watson, Melanie Glossop
  • Publication number: 20200231538
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: April 6, 2018
    Publication date: July 23, 2020
    Inventors: Melanie GLOSSOP, Christine WATSON
  • Publication number: 20200147236
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: April 6, 2018
    Publication date: May 14, 2020
    Inventors: Michael Westby, Melanie GLOSSOP, Christine WATSON, Christopher Pickford
  • Publication number: 20200069767
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: May 4, 2018
    Publication date: March 5, 2020
    Inventors: Michael Westby, Melanie GLOSSOP, Christine WATSON
  • Publication number: 20190248838
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: September 13, 2017
    Publication date: August 15, 2019
    Applicant: Centauri Therapeutics Limited (GB/GB)
    Inventors: Melanie GLOSSOP, Christine WATSON, Michael WESTBY
  • Publication number: 20180280521
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: October 7, 2016
    Publication date: October 4, 2018
    Inventors: Christopher PICKFORD, Christine WATSON, Melanie GLOSSOP
  • Patent number: 8193823
    Abstract: An assembly apparatus for measurement of electrical conductivity or other properties of a sample in a piston cylinder device wherein pressure and heat are applied to the sample by the piston cylinder device. The assembly apparatus includes a body, a first electrode in the body, the first electrode operatively connected to the sample, a first electrical conductor connected to the first electrode, a washer constructed of a hard conducting material, the washer surrounding the first electrical conductor in the body, a second electrode in the body, the second electrode operatively connected to the sample, and a second electrical conductor connected to the second electrode.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: June 5, 2012
    Assignee: Lawrence Livermore National Security, LLC
    Inventors: Heather Christine Watson, Jeffrey James Roberts
  • Publication number: 20100271055
    Abstract: An assembly apparatus for measurement of electrical conductivity or other properties of a sample in a piston cylinder device wherein pressure and heat are applied to the sample by the piston cylinder device. The assembly apparatus includes a body, a first electrode in the body, the first electrode operatively connected to the sample, a first electrical conductor connected to the first electrode, a washer constructed of a hard conducting material, the washer surrounding the first electrical conductor in the body, a second electrode in the body, the second electrode operatively connected to the sample, and a second electrical conductor connected to the second electrode.
    Type: Application
    Filed: April 23, 2009
    Publication date: October 28, 2010
    Inventors: Heather Christine Watson, Jeffery James Roberts
  • Publication number: 20070245666
    Abstract: A board suitable for installation on the side of a building has a front surface suitable for exposure to the weather, a rear surface, an upper end and a lower end, wherein the board has a stacking foot at either the upper end or lower end of the board, and has a stacking notch at the other of the upper end or lower end, with the stacking notch and the stacking foot enabling two of the boards to be stacked together with the stacking foot of each of the boards nested in the stacking notch of the other board, thereby providing stability for the stacked boards.
    Type: Application
    Filed: February 26, 2007
    Publication date: October 25, 2007
    Inventors: Christine Watson, Brian Guhde, Donn Vermilion, Thomas Grace, Joshua Dickman, Chris Cicenas
  • Publication number: 20070105831
    Abstract: The invention relates to compounds of formula processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.
    Type: Application
    Filed: September 18, 2006
    Publication date: May 10, 2007
    Inventors: Paul Glossop, Simon Mantell, Anthony Wood, Christine Watson